Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001641172-25-004819
Filing Date
2025-04-15
Accepted
2025-04-15 16:30:24
Documents
58
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 1390096
2 ex19-1.htm EX-19.1 158848
3 ex23-1.htm EX-23.1 4250
4 ex31-1.htm EX-31.1 12291
5 ex32-1.htm EX-32.1 3076
6 image_001.jpg GRAPHIC 5583
7 form10-k_001.jpg GRAPHIC 45591
8 form10-k_002.jpg GRAPHIC 30990
9 form10-k_003.jpg GRAPHIC 26541
10 form10-k_004.jpg GRAPHIC 23017
11 form10-k_005.jpg GRAPHIC 71365
12 form10-k_006.jpg GRAPHIC 48684
13 form10-k_007.jpg GRAPHIC 18765
14 fin_001.jpg GRAPHIC 5583
  Complete submission text file 0001641172-25-004819.txt   5070283

Data Files

Seq Description Document Type Size
15 XBRL SCHEMA FILE glsi-20241231.xsd EX-101.SCH 21465
16 XBRL CALCULATION FILE glsi-20241231_cal.xml EX-101.CAL 26352
17 XBRL DEFINITION FILE glsi-20241231_def.xml EX-101.DEF 105098
18 XBRL LABEL FILE glsi-20241231_lab.xml EX-101.LAB 265733
19 XBRL PRESENTATION FILE glsi-20241231_pre.xml EX-101.PRE 211189
60 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 283022
Mailing Address 3992 BLUEBONNET DR, BUILDING 14 STAFFORD TX 77477
Business Address 3992 BLUEBONNET DR, BUILDING 14 STAFFORD TX 77477 203-434-3290
Greenwich LifeSciences, Inc. (Filer) CIK: 0001799788 (see all company filings)

EIN.: 205473709 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39555 | Film No.: 25839944
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)